UREMIA AS A STATE OF IMMUNE DEFICIENCY

[1] BIRKELAND SA, 1975, ACTA PATH MICRO IM C, V83, P289

[2] BIRKELAND SA, IN PRESS

[3] BRIDGES JM, 1964, LANCET, V1, P581

[4] PROLONGED SURVIVAL OF SKIN HOMOGRAFTS IN UREMIC PATIENTS [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1957, 64 (05) : 967 - 976

[5] DANIELS JC, 1971, CLIN EXP IMMUNOL, V8, P213

[6] DANIELS JC, 1971, J RETICULOENDOTH SOC, V9, P409

[7] GOTTSEGEN G, 1937, KLIN WOCHENSCHR, V16, P275

[8] GUCKIAN JC, 1971, TEX REP BIOL MED, V29, P193

[9] SUPPRESSION OF IN-VITRO LYMPHOCYTE FUNCTION BY UREMIC TOXINS [J]. JOURNAL OF UROLOGY, 1972, 108 (02) : 312 - &

[10] HUBER H, 1969, CLIN EXP IMMUNOL, V5, P75

[1] BIRKELAND SA, 1975, ACTA PATH MICRO IM C, V83, P289

[2] BIRKELAND SA, IN PRESS

[3] BRIDGES JM, 1964, LANCET, V1, P581

[4] PROLONGED SURVIVAL OF SKIN HOMOGRAFTS IN UREMIC PATIENTS [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1957, 64 (05) : 967 - 976

[5] DANIELS JC, 1971, CLIN EXP IMMUNOL, V8, P213

[6] DANIELS JC, 1971, J RETICULOENDOTH SOC, V9, P409

[7] GOTTSEGEN G, 1937, KLIN WOCHENSCHR, V16, P275

[8] GUCKIAN JC, 1971, TEX REP BIOL MED, V29, P193

[9] SUPPRESSION OF IN-VITRO LYMPHOCYTE FUNCTION BY UREMIC TOXINS [J]. JOURNAL OF UROLOGY, 1972, 108 (02) : 312 - &

[10] HUBER H, 1969, CLIN EXP IMMUNOL, V5, P75